For more than two decades, the rules of global health financing were remarkably predictable. Countries battling HIV, tuberculosis (TB), and malaria could expect successive rounds…
Countries where the Global Fund invests are preparing their funding requests for the Global Fund’s Grant Cycle 8 (GC8) amid a significant shift in the…
As global health financing tightens, countries are increasingly being asked to do more with less. A stronger focus on integration is emerging as part of…
The global health financing landscape is changing. Donor priorities are evolving, fiscal pressures are tightening in many traditional funding countries, and there is increasing emphasis…
Warm greetings from the ACB! We are pleased to inform you that the Board of the ACB has concluded its recruitment process and appointed…
Addressed to the Ministers of Health of Central African region and the Country Coordinating Mechanisms, the ACB Secretariat and the Global Fund Secretariat. Introduction In…
Introduction Long-acting injectable ARVs are a major breakthrough in HIV prevention and treatment. They are used as pre-exposure prophylaxis for HIV-negative people, particularly those at…